ADMA logo

ADMA Biologics (ADMA) Long Term Debt

Annual Long Term Debt

$140.37 M
-$13.16 M-8.57%

31 December 2023

ADMA Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Debt

$110.19 M
-$30.07 M-21.44%

30 September 2024

ADMA Quarterly Long Term Debt Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADMA Long Term Debt Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-8.6%-27.5%
3 y3 years+44.3%+8.8%
5 y5 years+217.6%+31.0%

ADMA Long Term Debt High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-8.6%+44.3%-28.8%+8.8%
5 y5 years-8.6%+217.6%-28.8%+31.0%
alltimeall time-8.6%+3447.1%-28.8%>+9999.0%

ADMA Biologics Long Term Debt History

DateAnnualQuarterly
Sept 2024
-
$110.19 M(-21.4%)
June 2024
-
$140.26 M(-0.1%)
Mar 2024
-
$140.33 M(-0.0%)
Dec 2023
$140.37 M(-8.6%)
$140.37 M(-7.6%)
Sept 2023
-
$151.99 M(+1.0%)
June 2023
-
$150.53 M(-2.7%)
Mar 2023
-
$154.77 M(+0.8%)
Dec 2022
$153.54 M(+50.0%)
$153.54 M(+1.0%)
Sept 2022
-
$152.00 M(+0.9%)
June 2022
-
$150.68 M(+3.4%)
Mar 2022
-
$145.71 M(+42.4%)
Dec 2021
$102.33 M(+5.2%)
$102.33 M(+1.0%)
Sept 2021
-
$101.28 M(+0.3%)
June 2021
-
$100.95 M(+1.1%)
Mar 2021
-
$99.83 M(+2.6%)
Dec 2020
$97.30 M(+15.1%)
$97.30 M(-2.6%)
Sept 2020
-
$99.90 M(+0.4%)
June 2020
-
$99.51 M(+1.6%)
Mar 2020
-
$97.96 M(+15.9%)
Dec 2019
$84.50 M(+91.2%)
$84.50 M(+0.5%)
Sept 2019
-
$84.09 M(+0.4%)
June 2019
-
$83.77 M(+46.4%)
Mar 2019
-
$57.23 M(+29.5%)
Dec 2018
$44.19 M
$44.19 M(+0.7%)
Sept 2018
-
$43.91 M(+0.6%)
DateAnnualQuarterly
June 2018
-
$43.63 M(+0.9%)
Mar 2018
-
$43.23 M(+0.6%)
Dec 2017
$42.97 M(+204.5%)
$42.97 M(+37.9%)
Sept 2017
-
$31.16 M(+19.9%)
June 2017
-
$25.98 M(+105.4%)
Mar 2017
-
$12.65 M(-10.4%)
Dec 2016
$14.11 M(-10.2%)
$14.11 M(-9.6%)
Sept 2016
-
$15.61 M(-21.4%)
June 2016
-
$19.87 M(+25.4%)
Mar 2016
-
$15.85 M(+0.8%)
Dec 2015
$15.72 M(+6.5%)
$15.72 M(+0.8%)
Sept 2015
-
$15.59 M(+0.8%)
June 2015
-
$15.47 M(+2.6%)
Mar 2015
-
$15.07 M(+2.2%)
Dec 2014
$14.75 M(+191.4%)
$14.75 M(+46.8%)
Sept 2014
-
$10.05 M(+1.5%)
June 2014
-
$9.90 M(+0.3%)
Mar 2014
-
$9.87 M(+94.9%)
Dec 2013
$5.06 M(+27.9%)
$5.06 M(+0.4%)
Sept 2013
-
$5.04 M(+0.4%)
June 2013
-
$5.02 M(+0.4%)
Mar 2013
-
$5.00 M(+26.4%)
Dec 2012
$3.96 M
$3.96 M(+4779.7%)
Sept 2012
-
$81.10 K(-3.2%)
June 2012
-
$83.80 K(-3.3%)
Mar 2012
-
$86.70 K

FAQ

  • What is ADMA Biologics annual long term debt?
  • What is the all time high annual long term debt for ADMA Biologics?
  • What is ADMA Biologics annual long term debt year-on-year change?
  • What is ADMA Biologics quarterly long term debt?
  • What is the all time high quarterly long term debt for ADMA Biologics?
  • What is ADMA Biologics quarterly long term debt year-on-year change?

What is ADMA Biologics annual long term debt?

The current annual long term debt of ADMA is $140.37 M

What is the all time high annual long term debt for ADMA Biologics?

ADMA Biologics all-time high annual long term debt is $153.54 M

What is ADMA Biologics annual long term debt year-on-year change?

Over the past year, ADMA annual long term debt has changed by -$13.16 M (-8.57%)

What is ADMA Biologics quarterly long term debt?

The current quarterly long term debt of ADMA is $110.19 M

What is the all time high quarterly long term debt for ADMA Biologics?

ADMA Biologics all-time high quarterly long term debt is $154.77 M

What is ADMA Biologics quarterly long term debt year-on-year change?

Over the past year, ADMA quarterly long term debt has changed by -$41.80 M (-27.50%)